Quality of life Scale: 0 to 100 · patients with stable angina pectoris
1 finding from 1 review
AMI incidence · patients with stable angina pectoris
Ranolazine (monotherapy) showed no clear difference in AMI incidence compared with placebo (low certainty).
1 finding from 1 review
Angina episodes frequency · patients with stable angina pectoris
1 finding from 1 review
Adverse events incidence · patients with stable angina pectoris
It is very uncertain whether ranolazine (monotherapy) changes adverse events incidence compared with placebo (very low certainty).
1 finding from 1 review
Cardiovascular mortality · patients with stable angina pectoris
Ranolazine (monotherapy) showed no clear difference in cardiovascular mortality compared with placebo (low certainty).
1 finding from 1 review
Non‐cardiovascular mortality ‐ not reported · patients with stable angina pectoris
The review found no eligible studies for this question.
1 finding from 1 review
Cardiovascular mortality ‐ not measured · patients with stable angina pectoris
The review found no eligible studies for this question.
1 finding from 1 review
Non‐cardiovascular mortality ‐ not reported · patients with stable angina pectoris
The review found no eligible studies for this question.
1 finding from 1 review
All‐cause mortality · patients with stable angina pectoris
Ranolazine (add‐on therapy) showed no clear difference in all‐cause mortality compared with placebo (low certainty).
1 finding from 1 review
Quality of life Scale: 0 to 100. · patients with stable angina pectoris
1 finding from 1 review
AMI incidence · patients with stable angina pectoris
Ranolazine (add‐on therapy) showed no clear difference in AMI incidence compared with placebo (low certainty).
1 finding from 1 review
Angina episodes frequency · patients with stable angina pectoris
1 finding from 1 review
Adverse events incidence · patients with stable angina pectoris
Ranolazine (add‐on therapy) probably leads to higher adverse events incidence compared with placebo (moderate certainty).
1 finding from 1 review
Infectious complications · adults diagnosed with coronary artery disease or cardiac valve disease, and candidates for cardiac surgery with cardiopulmonary bypass
Prophylactic corticosteroids may leads to lower infectious complications (as defined by study authors, including… compared with placebo or no corticosteroids (low certainty).
1 finding from 1 review
New initiation of renal replacement therapy – at longest available · people with AHF
Ultrafiltration (UF) showed no clear difference in new initiation of renal replacement therapy – at longest available compared with usual care (UC) (low certainty).
1 finding from 1 review
Intervention not reported
Discontinuation of therapy due to adverse effects · patients in primary prevention of cardiovascular disease events
It is very uncertain whether the intervention changes discontinuation of therapy due to adverse effects (very low certainty).
1 finding from 1 review
Intervention not reported
Adverse effects necessitating stop of therapy Patient reported
The intervention probably leads to higher adverse effects necessitating stop of therapy Patient reported (moderate certainty).
1 finding from 1 review
Intervention not reported
Number of patients with arrhythmia: Garlicin injection plus supportive therapy versus supportive therapy alone · patients with viral myocarditis
It is very uncertain whether the intervention changes number of patients with arrhythmia: Garlicin injection plus… (very low certainty).
1 finding from 1 review
Intervention not reported
Number of patients with arrhythmia: Danhong injection plus supportive therapy versus supportive therapy alone · patients with viral myocarditis
The intervention showed no clear difference in number of patients with arrhythmia: Danhong injection plus… (moderate certainty).
1 finding from 1 review
Intervention not reported
Number of patients with premature beat: Astragaloside injection plus supportive therapy versus Acyclovir plus supportive therapy · patients with viral myocarditis
It is very uncertain whether the intervention changes number of patients with premature beat: Astragaloside injection plus… (very low certainty).
1 finding from 1 review